Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADL5859 and ADL5747 in Osteoarthritis of the Knee
NCT00979953Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ADL5859, ADL-5747 in knee osteoarthritis (OA), sponsored by Merck & Co.. Started Oct 2009; status: completed.
02
Drugs
ADL5859ADL-5747
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00979953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979953.